|
1
|
Brown LM, Devesa SS and Chow WH: Incidence
of adenocarcinoma of the esophagus among white Americans by sex,
stage, and age. J Natl Cancer Inst. 100:1184–1187. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sharma P: Clinical practice. Barrett’s
esophagus. New Engl J Med. 361:2548–2556. 2009.
|
|
3
|
Tsai RY: A molecular view of stem cell and
cancer cell self-renewal. Int J Biochem Cell Biol. 36:684–694.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kopper L and Hajdú M: Tumor stem cells.
Pathol Oncol Res. 10:69–73. 2004. View Article : Google Scholar
|
|
5
|
Chew JL, Loh YH, Zhang W, et al:
Reciprocal transcriptional regulation of Pou5f1 and
Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol
Cell Biol. 25:6031–6046. 2005.PubMed/NCBI
|
|
6
|
Okumura-Nakanishi S, Saito M, Niwa H and
Ishikawa F: Oct-3/4 and Sox2 regulate Oct-3/4 gene in
embryonic stem cells. J Biol Chem. 280:5307–5317. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang X, Sun Y, Xu M, Fang DC, Gao HJ and
Xu JT: Oligomicroarray-based primary study of gene expression
profile changes in Barrett’s esophagus. Journal of Medical Colleges
of PLA. 23:251–257. 2008.
|
|
8
|
Rockett JC, Larkin K, Darnton SJ, Morris
AG and Matthews HR: Five newly established oesophageal carcinoma
cell lines: phenotypic and immunological characterization. Br J
Cancer. 75:258–263. 1997. View Article : Google Scholar
|
|
9
|
Okamoto K, Okazawa H, Okuda A, Sakai M,
Muramatsu M and Hamada H: A novel octamer binding transcription
factor is differentially expressed in mouse embryonic cells. Cell.
60:461–472. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pesce M and Schöler HR: Oct-4:
gatekeeper in the beginnings of mammalian development. Stem Cells.
19:271–278. 2001. View Article : Google Scholar
|
|
11
|
Schöler HR: the POU factors in murine
development. Trends Genet. 7:323–329. 1991.
|
|
12
|
Weiss MA: Floppy SOX: mutual induced fit
in hmg (high-mobility group) box-DNA recognition. Mol Endocrinol.
15:353–362. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wegner M: From head to toes: the multiple
facets of Sox proteins. Nucleic Acids Res. 27:1409–1420. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boiani M and Schöler HR: Regulatory
networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell
Biol. 6:872–884. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin T, Branch DR, Zhang X, et al:
Examination of POU homeobox gene expression in human breast
cancer cells. Int J Cancer. 81:104–112. 1999.
|
|
16
|
Rodriguez-Pinilla SM, Sarrio D,
Moreno-Bueno G, et al: Sox2: a possible driver of the basal-like
phenotype in sporadic breast cancer. Mod Pathol. 20:474–481. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jones TD, Ulbright TM, Eble JN and Cheng
L: OCT4: a sensitive and specific biomarker for intratubular germ
cell neoplasia of the testis. Clin Cancer Res. 10:8544–8547. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rijlaarsdam MA, van Herk HA, Gillis AJ, et
al: Specific detection of OCT3/4 isoform A/B/B1 expression in solid
(germ cell) tumours and cell lines: confirmation of OCT3/4
specificity for germ cell tumours. Br J Cancer. 105:854–863. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iki K and Pour PM: Expression of Oct4, a
stem cell marker, in the hamster pancreatic cancer model.
Pancreatology. 6:406–413. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sanada Y, Yoshida K, Ohara M, Oeda M,
Konishi K and Tsutani Y: Histopathologic evaluation of stepwise
progression of pancreatic carcinoma with immunohistochemical
analysis of gastric epithelial transcription factor SOX2:
comparison of expression patterns between invasive components and
cancerous or nonneoplastic intraductal components. Pancreas.
32:164–170. 2006.
|
|
21
|
Tai MH, Chang CC, Kiupel M, Webster JD,
Olson LK and Trosko JE: Oct4 expression in adult human stem cells:
evidence in support of the stem cell theory of carcinogenesis.
Carcinogenesis. 26:495–502. 2005.PubMed/NCBI
|
|
22
|
Ben-Porath I, Thomson MW, Carey VJ, et al:
An embryonic stem cell-like gene expression signature in poorly
differentiated aggressive human tumors. Nat Genet. 40:499–507.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karoubi G, Gugger M, Schmid R and Dutly A:
OCT4 expression in human non-small cell lung cancer: implications
for therapeutic intervention. Interact Cardiovasc Thorac Surg.
8:393–397. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rao P, Tannir NM and Tamboli P: Expression
of OCT3/4 in renal medullary carcinoma represents a potential
diagnostic pitfall. Am J Surg Pathol. 36:583–588. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ivanova N, Dobrin R, Lu R, et al:
Dissecting self-renewal in stem cells with RNA interference.
Nature. 442:533–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pekarsky Y, Koval A, Hallas C, et al: Tcl1
enhances Akt kinase activity and mediates its nuclear
translocation. Proc Natl Acad Sci USA. 97:3028–3033. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Watanabe S, Umehara H, Murayama K, Okabe
M, Kimura T and Nakano T: Activation of Akt signaling is sufficient
to maintain pluripotency in mouse and primate embryonic stem cells.
Oncogene. 25:2697–2707. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matoba R, Niwa H, Masui S, et al:
Dissecting Oct3/4-regulated gene networks in embryonic stem cells
by expression profiling. PLoS One. 1:e262006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lapidot T, Sirard C, Vormoor J, et al: A
cell initiating human acute myeloid leukaemia after transplantation
into SCID mice. Nature. 367:645–648. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Singh SK, Clarke ID, Hide T and Dirks PB:
Cancer stem cells in nervous system tumors. Oncogene. 23:7267–7273.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Suetsugu A, Nagaki M, Aoki H, Motohashi T,
Kunisada T and Moriwaki H: Characterization of CD133+
hepatocellular carcinoma cells as cancer stem/progenitor cells.
Biochem Biophys Res Commun. 351:820–824. 2006.
|
|
36
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
37
|
Prince ME, Sivanandan R, Kaczorowski A, et
al: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhou S, Sehuetz JD, Bunting KD, et al: The
ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem
cells and is a molecular determinant of the side-population
phenotype. Nat Med. 7:1028–1034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bunting KD: ABC transporters as phenotypic
markers and functional regulators of stem cells. Stem Cells.
20:11–20. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hirschmann-Jax C, Foster AE, Wulf GG, et
al: A distinct ‘side population’ of cells with high drug efflux
capacity in human tumor cells. Proc Natl Acad Sci USA.
101:14228–14233. 2004.
|
|
41
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, et al: Ovarian cancer side population defines cells with stem
cell-like characteristics and mullerian inhibiting substance
responsiveness. Proc Natl Acad Sci USA. 103:11154–11159. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang J, Niu C, Ye L, et al:
Identification of the haematopoietic stem cells niche and control
of the niche size. Nature. 425:836–841. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li N, Yang H, Lu L, Duan C, Zhao C and
Zhao H: Comparison of the labeling efficiency of BrdU, DiI and FISH
labeling techniques in bone marrow stromal cells. Brain Res.
1215:11–19. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Potten CS, Owen G and Booth D: Intestinal
stem cells protect their genome by selective segregation of
template DNA strands. J Cell Sci. 115:2381–2388. 2002.PubMed/NCBI
|
|
45
|
Smith GH: Label-retaining epithelial cells
in mouse mammary gland divide asymmetrically and retain their
template DNA strands. Development. 132:681–687. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Taylor G, Lehrer MS, Jensen PJ, Sun TT and
Lavker RM: Involvement of follicular stem cells in forming not only
the follicle but also the epidermis. Cell. 102:451–461. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sun TT and Lavker RM: Corneal epithelial
stem cells: past, present, and future. J Investig Dermatol Symp
Proc. 9:202–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
McManus MT and Sharp PA: Gene silencing in
mammals by small interfering RNAs. Nat Rev Genet. 3:737–747. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang J and Hua ZC: Targeted gene
silencing by small interfering RNA-based knock-down technology.
Curr Pharm Biotechnol. 5:1–7. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Monk M and Holding C: Human embryonic
genes re-expressed in cancer cells. Oncogene. 20:8085–8091. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Atlasi Y, Mowla SJ, Ziaee SA and Bahrami
AR: OCT-4, an embryonic stem cell marker, is highly
expressed in bladder cancer. Int J Cancer. 120:1598–1602. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Nichols J, Zevnik B, Anastassiadis K, et
al: Formation of pluripotent stem cells in the mammalian embryo
depends on the POU transcription factor Oct4. Cell. 95:379–391.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Niwa H, Miyazaki J and Smith AG:
Quantitative expression of Oct-3/4 defines differentiation,
dedifferentiation or self-renewal of ES cells. Nat Genet.
24:372–376. 2000. View
Article : Google Scholar : PubMed/NCBI
|
